| DNA Hypermethylation Inhibits the CD82 Metastasis Suppressor Gene in Gastric Cancer. | DNA Hypermethylation Inhibits the CD82 Metastasis Suppressor Gene in Gastric Cancer.
Park JW, Kim W, Kang HG, Kim WJ, Lee H, Choi D, Kim SJ. | 07/5/2024 |
| CD81 and CD82 expressing tumor-infiltrating lymphocytes in the NSCLC tumor microenvironment play a crucial role in T-cell activation and cytokine production. | CD81 and CD82 expressing tumor-infiltrating lymphocytes in the NSCLC tumor microenvironment play a crucial role in T-cell activation and cytokine production.
Na K, Lee S, Kim DK, Kim YS, Hwang JY, Kang SS, Baek S, Lee CY, Yang SM, Han YJ, Kim MH, Han H, Kim Y, Kim JH, Jeon S, Byeon Y, Lee JB, Lim SM, Hong MH, Pyo KH, Cho BC., Free PMC Article | 03/26/2024 |
| Tetraspanin CD82 Correlates with and May Regulate S100A7 Expression in Oral Cancer. | Tetraspanin CD82 Correlates with and May Regulate S100A7 Expression in Oral Cancer.
Reddi KK, Zhang W, Shahrabi-Farahani S, Anderson KM, Liu M, Kakhniashvili D, Wang X, Zhang YH., Free PMC Article | 03/14/2024 |
| Tetraspanin CD82 Associates with Trafficking Vesicle in Muscle Cells and Binds to Dysferlin and Myoferlin. | Tetraspanin CD82 Associates with Trafficking Vesicle in Muscle Cells and Binds to Dysferlin and Myoferlin.
Fontelonga T, Hall AJ, Brown JL, Jung YL, Alexander MS, Dominov JA, Mouly V, Vieira N, Zatz M, Vainzof M, Gussoni E., | 12/22/2023 |
| Expression of KAI1 and AGR2 in lung adenocarcinoma and their clinicopathological significance. | Expression of KAI1 and AGR2 in lung adenocarcinoma and their clinicopathological significance.
Ci H, Wu L., Free PMC Article | 01/11/2023 |
| Lower expression of KAI1 as a biomarker of poor survival prognosis of melanoma combined with colorectal cancer metastasis. | Lower expression of KAI1 as a biomarker of poor survival prognosis of melanoma combined with colorectal cancer metastasis.
Du X, Wang B, Liu L, Li Y, Wang ZX, Zhang GJ, Yang XF., Free PMC Article | 08/20/2022 |
| Proteomic profiling of plasma exosomes reveals CD82 involvement in the development of esophageal squamous cell carcinoma. | Proteomic profiling of plasma exosomes reveals CD82 involvement in the development of esophageal squamous cell carcinoma.
Yang L, Salai A, Sun X, Liu Q, Liu T, Zhang Q, Tuerxun A, Tan Y, Zheng S, Lu X. | 07/16/2022 |
| A positive COX-2/IL-1beta loop promotes decidualization by upregulating CD82. | A positive COX-2/IL-1β loop promotes decidualization by upregulating CD82.
Qu QC, Shen HH, Wang CJ, Zhang XY, Wu JN, Lu HC, Qiu XM, Ding JY, Tan XF, Liu LB, Li MQ. | 03/19/2022 |
| The Role of CK7, S100A1, and CD82 (KAI1) Expression in the Differential Diagnosis of Chromophobe Renal Cell Carcinoma and Renal Oncocytoma. | The Role of CK7, S100A1, and CD82 (KAI1) Expression in the Differential Diagnosis of Chromophobe Renal Cell Carcinoma and Renal Oncocytoma.
Sari ZB, Açikalin MF, Arik D, Özen A, Can C, Çolak E. | 01/22/2022 |
| CD82 is a marker to isolate beta cell precursors from human iPS cells and plays a role for the maturation of beta cells. | CD82 is a marker to isolate β cell precursors from human iPS cells and plays a role for the maturation of β cells.
Watanabe A, Tanaka A, Koga C, Matsumoto M, Okazaki Y, Kin T, Miyajima A., Free PMC Article | 10/30/2021 |
| Mechanical Control of Cell Migration by the Metastasis Suppressor Tetraspanin CD82/KAI1. | Mechanical Control of Cell Migration by the Metastasis Suppressor Tetraspanin CD82/KAI1.
Ordas L, Costa L, Lozano A, Chevillard C, Calovoulos A, Kantar D, Fernandez L, Chauvin L, Dosset P, Doucet C, Heron-Milhavet L, Odintsova E, Berditchevski F, Milhiet PE, Bénistant C., Free PMC Article | 10/30/2021 |
| CD82 and Gangliosides Tune CD81 Membrane Behavior. | CD82 and Gangliosides Tune CD81 Membrane Behavior.
Fernandez L, Malrieu M, Bénistant C, Dosset P, Rubinstein E, Odintsova E, Berditchevski F, Milhiet PE., Free PMC Article | 09/25/2021 |
| CD82 Suppresses ADAM17-Dependent E-Cadherin Cleavage and Cell Migration in Prostate Cancer. | CD82 Suppresses ADAM17-Dependent E-Cadherin Cleavage and Cell Migration in Prostate Cancer.
Ma Z, Gao Y, Liu W, Zheng L, Jin B, Duan B, Xie H, Guo P, Zeng J, Wang K, Xu S, Wang X, He D, Li L., Free PMC Article | 08/14/2021 |
| Small extracellular ring domain is necessary for CD82/KAI1'anti-metastasis function. | Small extracellular ring domain is necessary for CD82/KAI1'anti-metastasis function.
Ma X, He X, Wang C, Huang X, Li Y, Ma K. | 08/7/2021 |
| Diagnostic utility of amylase alpha-1A, MOC 31, and CD 82 in renal oncocytoma versus chromophobe renal cell carcinoma. | Diagnostic utility of amylase α-1A, MOC 31, and CD 82 in renal oncocytoma versus chromophobe renal cell carcinoma.
Abouhashem NS, Abdelbary EH, H Abdalla MM, El-Shazly M. | 06/12/2021 |
| Investigations of a Possible Role of SNPs in KAI1 Gene on Its Down-Regulation in Breast Cancer. | Investigations of a Possible Role of SNPs in KAI1 Gene on Its Down-Regulation in Breast Cancer.
Kussaibi H, Alkharsah KR., Free PMC Article | 06/12/2021 |
| Gene expression analysis of human prostate cell lines with and without tumor metastasis suppressor CD82. | Gene expression analysis of human prostate cell lines with and without tumor metastasis suppressor CD82.
Dodla P, Bhoopalan V, Khoo SK, Miranti C, Sridhar S., Free PMC Article | 04/24/2021 |
| Effects of KAI gene expression on ferroptosis in pancreatic cancer cells. | Effects of KAI gene expression on ferroptosis in pancreatic cancer cells.
Liu X, Guo X, Li H, Chen J, Han H. | 04/3/2021 |
| Tetraspanin CD82 drives acute myeloid leukemia chemoresistance by modulating protein kinase C alpha and beta1 integrin activation. | Tetraspanin CD82 drives acute myeloid leukemia chemoresistance by modulating protein kinase C alpha and β1 integrin activation.
Floren M, Restrepo Cruz S, Termini CM, Marjon KD, Lidke KA, Gillette JM., Free PMC Article | 11/28/2020 |
| CD82 accelerated beta-catenin nuclear location and then stimulated the expression of downstream molecules of Wnt/beta-catenin pathway | CD82 supports survival of childhood acute myeloid leukemia cells via activation of Wnt/β-catenin signaling pathway.
Ji H, Chen L, Xing Y, Li S, Dai J, Zhao P, Wang Y. | 05/9/2020 |
| Down Regulation of KAI1 is associated with Breast Cancer. | Down Regulation of KAI1/CD82 in Lymph Node Positive and Advanced T-Stage Group in Breast Cancer Patients.
Krishna Latha T, Verma A, Thakur GK, Banerjee B, Kaur N, Singh UR, Sharma S., Free PMC Article | 04/18/2020 |
| KAI1 reversed EMT-related marker expression and inhibited migration and invasion of PC cells. | KAI1 reverses the epithelial-mesenchymal transition in human pancreatic cancer cells.
Liu X, Guo XZ, Li HY, Chen J. | 03/28/2020 |
| these data demonstrate that CD82 organizes the proper assembly of Dectin-1 signaling machinery in response to Candida albicans | Tetraspanin CD82 Organizes Dectin-1 into Signaling Domains to Mediate Cellular Responses to Candida albicans.
Tam JM, Reedy JL, Lukason DP, Kuna SG, Acharya M, Khan NS, Negoro PE, Xu S, Ward RA, Feldman MB, Dutko RA, Jeffery JB, Sokolovska A, Wivagg CN, Lassen KG, Le Naour F, Matzaraki V, Garner EC, Xavier RJ, Kumar V, van de Veerdonk FL, Netea MG, Miranti CK, Mansour MK, Vyas JM., Free PMC Article | 02/29/2020 |
| A variant on CD82 gene (rs2303861 polymorphism) may have a role in the development and progression of non-alcoholic fatty liver disease | Association between rs2303861 polymorphism in CD82 gene and non-alcoholic fatty liver disease: a preliminary case-control study.
Habibzadeh P, Honarvar B, Silawi M, Bahramjahan S, Kazemi A, Faghihi MA, Lankarani K., Free PMC Article | 02/1/2020 |
| Results found that low expression of CD82/KAI1 in esophageal squamous cell carcinoma (ESCC) was significantly associated with the pathological stage, distant metastasis and poor prognosis of ESCC patients. CD82/KAI1 may inhibit the malignant progression of ESCC by interacting with TGF-beta1. | CD82/KAI1 inhibits invasion and metastasis of esophageal squamous cell carcinoma via TGF-β1.
Zeng TD, Zheng B, Zheng W, Chen C. | 12/7/2019 |